ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pleuromutilin Antibiotic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8O15828
Home | Market Reports | Health| Pharmacy
Global Pleuromutilin Antibiotic Market Research Report 2023
BUY CHAPTERS

Global Pleuromutilin Antibiotic Market Research Report 2025

Code: QYRE-Auto-8O15828
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sunny Biotech
Hebei Weiyuan
Shandong Shengli
Shandong Lukang
Qilu Pharma
Huvepharma
Novartis
Vethellas S.A.
Elanco
Qingdao Dierman

Pleuromutilin Antibiotic Market Size

The global market for Pleuromutilin Antibiotic was valued at US$ 90.4 million in the year 2024 and is projected to reach a revised size of US$ 126 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Pleuromutilin Antibiotic Market

Pleuromutilin Antibiotic Market

Pleuromutilin is a broad-spectrum diterpene antibiotic produced by Pleurotus mutilus. It is the precursor of semi-synthetic derivatives of pleuromutilin and can effectively inhibit most Gram-negative bacteria. positive bacteria and some Gram-negative bacteria.
Pleuromutilin’s market is driven by its effectiveness against specific bacterial infections and its widespread use in the veterinary and poultry medicine sectors. Its successful application in veterinary medicine and increasing demand have propelled market growth. Additionally, concerns about antibiotic resistance have prompted the livestock industry to adopt more sustainable veterinary medicines, with Pleuromutilin being considered a relatively low-resistance option, further boosting market demand. However, the Pleuromutilin market also faces several challenges. One of these challenges is the continuous rise in antibiotic resistance, which may limit its long-term effectiveness. Furthermore, some regions and markets may have stricter regulations on antibiotic use, posing challenges to market access for Pleuromutilin. Additionally, the veterinary sector’s interest in alternative treatment methods and greener veterinary medicines could impact the growth of the Pleuromutilin market. Therefore, the market needs to continually address challenges such as antibiotic resistance and regulatory restrictions to maintain sustainable growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pleuromutilin Antibiotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pleuromutilin Antibiotic.
The Pleuromutilin Antibiotic market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pleuromutilin Antibiotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pleuromutilin Antibiotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pleuromutilin Antibiotic Market Report

Report Metric Details
Report Name Pleuromutilin Antibiotic Market
Accounted market size in year US$ 90.4 million
Forecasted market size in 2031 US$ 126 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Livestock
  • Poultry
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, Qingdao Dierman, Qilu Pharma, Huvepharma, Novartis, Vethellas, Elanco
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pleuromutilin Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pleuromutilin Antibiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pleuromutilin Antibiotic Market growing?

Ans: The Pleuromutilin Antibiotic Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Pleuromutilin Antibiotic Market size in 2031?

Ans: The Pleuromutilin Antibiotic Market size in 2031 will be US$ 126 million.

Who are the main players in the Pleuromutilin Antibiotic Market report?

Ans: The main players in the Pleuromutilin Antibiotic Market are Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, Qingdao Dierman, Qilu Pharma, Huvepharma, Novartis, Vethellas, Elanco

What are the Application segmentation covered in the Pleuromutilin Antibiotic Market report?

Ans: The Applications covered in the Pleuromutilin Antibiotic Market report are Livestock, Poultry

What are the Type segmentation covered in the Pleuromutilin Antibiotic Market report?

Ans: The Types covered in the Pleuromutilin Antibiotic Market report are Premix, API Powder

Recommended Reports

Antibiotic And Resistance

Respiratory And Pulmonary

Veterinary And Livestock

1 Pleuromutilin Antibiotic Market Overview
1.1 Product Definition
1.2 Pleuromutilin Antibiotic by Type
1.2.1 Global Pleuromutilin Antibiotic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Premix
1.2.3 API Powder
1.3 Pleuromutilin Antibiotic by Application
1.3.1 Global Pleuromutilin Antibiotic Market Value by Application (2024 VS 2031)
1.3.2 Livestock
1.3.3 Poultry
1.4 Global Pleuromutilin Antibiotic Market Size Estimates and Forecasts
1.4.1 Global Pleuromutilin Antibiotic Revenue 2020-2031
1.4.2 Global Pleuromutilin Antibiotic Sales 2020-2031
1.4.3 Global Pleuromutilin Antibiotic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pleuromutilin Antibiotic Market Competition by Manufacturers
2.1 Global Pleuromutilin Antibiotic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pleuromutilin Antibiotic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pleuromutilin Antibiotic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pleuromutilin Antibiotic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pleuromutilin Antibiotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pleuromutilin Antibiotic, Product Type & Application
2.7 Global Key Manufacturers of Pleuromutilin Antibiotic, Date of Enter into This Industry
2.8 Global Pleuromutilin Antibiotic Market Competitive Situation and Trends
2.8.1 Global Pleuromutilin Antibiotic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pleuromutilin Antibiotic Players Market Share by Revenue
2.8.3 Global Pleuromutilin Antibiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pleuromutilin Antibiotic Market Scenario by Region
3.1 Global Pleuromutilin Antibiotic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pleuromutilin Antibiotic Sales by Region: 2020-2031
3.2.1 Global Pleuromutilin Antibiotic Sales by Region: 2020-2025
3.2.2 Global Pleuromutilin Antibiotic Sales by Region: 2026-2031
3.3 Global Pleuromutilin Antibiotic Revenue by Region: 2020-2031
3.3.1 Global Pleuromutilin Antibiotic Revenue by Region: 2020-2025
3.3.2 Global Pleuromutilin Antibiotic Revenue by Region: 2026-2031
3.4 North America Pleuromutilin Antibiotic Market Facts & Figures by Country
3.4.1 North America Pleuromutilin Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pleuromutilin Antibiotic Sales by Country (2020-2031)
3.4.3 North America Pleuromutilin Antibiotic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pleuromutilin Antibiotic Market Facts & Figures by Country
3.5.1 Europe Pleuromutilin Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pleuromutilin Antibiotic Sales by Country (2020-2031)
3.5.3 Europe Pleuromutilin Antibiotic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pleuromutilin Antibiotic Market Facts & Figures by Region
3.6.1 Asia Pacific Pleuromutilin Antibiotic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pleuromutilin Antibiotic Sales by Region (2020-2031)
3.6.3 Asia Pacific Pleuromutilin Antibiotic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pleuromutilin Antibiotic Market Facts & Figures by Country
3.7.1 Latin America Pleuromutilin Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pleuromutilin Antibiotic Sales by Country (2020-2031)
3.7.3 Latin America Pleuromutilin Antibiotic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pleuromutilin Antibiotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Pleuromutilin Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pleuromutilin Antibiotic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pleuromutilin Antibiotic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pleuromutilin Antibiotic Sales by Type (2020-2031)
4.1.1 Global Pleuromutilin Antibiotic Sales by Type (2020-2025)
4.1.2 Global Pleuromutilin Antibiotic Sales by Type (2026-2031)
4.1.3 Global Pleuromutilin Antibiotic Sales Market Share by Type (2020-2031)
4.2 Global Pleuromutilin Antibiotic Revenue by Type (2020-2031)
4.2.1 Global Pleuromutilin Antibiotic Revenue by Type (2020-2025)
4.2.2 Global Pleuromutilin Antibiotic Revenue by Type (2026-2031)
4.2.3 Global Pleuromutilin Antibiotic Revenue Market Share by Type (2020-2031)
4.3 Global Pleuromutilin Antibiotic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pleuromutilin Antibiotic Sales by Application (2020-2031)
5.1.1 Global Pleuromutilin Antibiotic Sales by Application (2020-2025)
5.1.2 Global Pleuromutilin Antibiotic Sales by Application (2026-2031)
5.1.3 Global Pleuromutilin Antibiotic Sales Market Share by Application (2020-2031)
5.2 Global Pleuromutilin Antibiotic Revenue by Application (2020-2031)
5.2.1 Global Pleuromutilin Antibiotic Revenue by Application (2020-2025)
5.2.2 Global Pleuromutilin Antibiotic Revenue by Application (2026-2031)
5.2.3 Global Pleuromutilin Antibiotic Revenue Market Share by Application (2020-2031)
5.3 Global Pleuromutilin Antibiotic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sunny Biotech
6.1.1 Sunny Biotech Company Information
6.1.2 Sunny Biotech Description and Business Overview
6.1.3 Sunny Biotech Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sunny Biotech Pleuromutilin Antibiotic Product Portfolio
6.1.5 Sunny Biotech Recent Developments/Updates
6.2 Hebei Weiyuan
6.2.1 Hebei Weiyuan Company Information
6.2.2 Hebei Weiyuan Description and Business Overview
6.2.3 Hebei Weiyuan Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hebei Weiyuan Pleuromutilin Antibiotic Product Portfolio
6.2.5 Hebei Weiyuan Recent Developments/Updates
6.3 Shandong Shengli
6.3.1 Shandong Shengli Company Information
6.3.2 Shandong Shengli Description and Business Overview
6.3.3 Shandong Shengli Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shandong Shengli Pleuromutilin Antibiotic Product Portfolio
6.3.5 Shandong Shengli Recent Developments/Updates
6.4 Shandong Lukang
6.4.1 Shandong Lukang Company Information
6.4.2 Shandong Lukang Description and Business Overview
6.4.3 Shandong Lukang Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shandong Lukang Pleuromutilin Antibiotic Product Portfolio
6.4.5 Shandong Lukang Recent Developments/Updates
6.5 Qingdao Dierman
6.5.1 Qingdao Dierman Company Information
6.5.2 Qingdao Dierman Description and Business Overview
6.5.3 Qingdao Dierman Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qingdao Dierman Pleuromutilin Antibiotic Product Portfolio
6.5.5 Qingdao Dierman Recent Developments/Updates
6.6 Qilu Pharma
6.6.1 Qilu Pharma Company Information
6.6.2 Qilu Pharma Description and Business Overview
6.6.3 Qilu Pharma Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Pharma Pleuromutilin Antibiotic Product Portfolio
6.6.5 Qilu Pharma Recent Developments/Updates
6.7 Huvepharma
6.7.1 Huvepharma Company Information
6.7.2 Huvepharma Description and Business Overview
6.7.3 Huvepharma Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huvepharma Pleuromutilin Antibiotic Product Portfolio
6.7.5 Huvepharma Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Pleuromutilin Antibiotic Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Vethellas
6.9.1 Vethellas Company Information
6.9.2 Vethellas Description and Business Overview
6.9.3 Vethellas Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vethellas Pleuromutilin Antibiotic Product Portfolio
6.9.5 Vethellas Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Pleuromutilin Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elanco Pleuromutilin Antibiotic Product Portfolio
6.10.5 Elanco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pleuromutilin Antibiotic Industry Chain Analysis
7.2 Pleuromutilin Antibiotic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pleuromutilin Antibiotic Production Mode & Process Analysis
7.4 Pleuromutilin Antibiotic Sales and Marketing
7.4.1 Pleuromutilin Antibiotic Sales Channels
7.4.2 Pleuromutilin Antibiotic Distributors
7.5 Pleuromutilin Antibiotic Customer Analysis
8 Pleuromutilin Antibiotic Market Dynamics
8.1 Pleuromutilin Antibiotic Industry Trends
8.2 Pleuromutilin Antibiotic Market Drivers
8.3 Pleuromutilin Antibiotic Market Challenges
8.4 Pleuromutilin Antibiotic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sunny Biotech
Hebei Weiyuan
Shandong Shengli
Shandong Lukang
Qilu Pharma
Huvepharma
Novartis
Vethellas S.A.
Elanco
Qingdao Dierman
List of Tables
 Table 1. Global Pleuromutilin Antibiotic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pleuromutilin Antibiotic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pleuromutilin Antibiotic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pleuromutilin Antibiotic Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Pleuromutilin Antibiotic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pleuromutilin Antibiotic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pleuromutilin Antibiotic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pleuromutilin Antibiotic Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pleuromutilin Antibiotic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pleuromutilin Antibiotic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pleuromutilin Antibiotic, Product Type & Application
 Table 12. Global Key Manufacturers of Pleuromutilin Antibiotic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pleuromutilin Antibiotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pleuromutilin Antibiotic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pleuromutilin Antibiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pleuromutilin Antibiotic Sales by Region (2020-2025) & (MT)
 Table 18. Global Pleuromutilin Antibiotic Sales Market Share by Region (2020-2025)
 Table 19. Global Pleuromutilin Antibiotic Sales by Region (2026-2031) & (MT)
 Table 20. Global Pleuromutilin Antibiotic Sales Market Share by Region (2026-2031)
 Table 21. Global Pleuromutilin Antibiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pleuromutilin Antibiotic Revenue Market Share by Region (2020-2025)
 Table 23. Global Pleuromutilin Antibiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pleuromutilin Antibiotic Revenue Market Share by Region (2026-2031)
 Table 25. North America Pleuromutilin Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pleuromutilin Antibiotic Sales by Country (2020-2025) & (MT)
 Table 27. North America Pleuromutilin Antibiotic Sales by Country (2026-2031) & (MT)
 Table 28. North America Pleuromutilin Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pleuromutilin Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pleuromutilin Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pleuromutilin Antibiotic Sales by Country (2020-2025) & (MT)
 Table 32. Europe Pleuromutilin Antibiotic Sales by Country (2026-2031) & (MT)
 Table 33. Europe Pleuromutilin Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pleuromutilin Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pleuromutilin Antibiotic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pleuromutilin Antibiotic Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Pleuromutilin Antibiotic Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Pleuromutilin Antibiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pleuromutilin Antibiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pleuromutilin Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pleuromutilin Antibiotic Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Pleuromutilin Antibiotic Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Pleuromutilin Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pleuromutilin Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pleuromutilin Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pleuromutilin Antibiotic Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Pleuromutilin Antibiotic Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Pleuromutilin Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pleuromutilin Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pleuromutilin Antibiotic Sales (MT) by Type (2020-2025)
 Table 51. Global Pleuromutilin Antibiotic Sales (MT) by Type (2026-2031)
 Table 52. Global Pleuromutilin Antibiotic Sales Market Share by Type (2020-2025)
 Table 53. Global Pleuromutilin Antibiotic Sales Market Share by Type (2026-2031)
 Table 54. Global Pleuromutilin Antibiotic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pleuromutilin Antibiotic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pleuromutilin Antibiotic Revenue Market Share by Type (2020-2025)
 Table 57. Global Pleuromutilin Antibiotic Revenue Market Share by Type (2026-2031)
 Table 58. Global Pleuromutilin Antibiotic Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Pleuromutilin Antibiotic Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Pleuromutilin Antibiotic Sales (MT) by Application (2020-2025)
 Table 61. Global Pleuromutilin Antibiotic Sales (MT) by Application (2026-2031)
 Table 62. Global Pleuromutilin Antibiotic Sales Market Share by Application (2020-2025)
 Table 63. Global Pleuromutilin Antibiotic Sales Market Share by Application (2026-2031)
 Table 64. Global Pleuromutilin Antibiotic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pleuromutilin Antibiotic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pleuromutilin Antibiotic Revenue Market Share by Application (2020-2025)
 Table 67. Global Pleuromutilin Antibiotic Revenue Market Share by Application (2026-2031)
 Table 68. Global Pleuromutilin Antibiotic Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Pleuromutilin Antibiotic Price (US$/Kg) by Application (2026-2031)
 Table 70. Sunny Biotech Company Information
 Table 71. Sunny Biotech Description and Business Overview
 Table 72. Sunny Biotech Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Sunny Biotech Pleuromutilin Antibiotic Product
 Table 74. Sunny Biotech Recent Developments/Updates
 Table 75. Hebei Weiyuan Company Information
 Table 76. Hebei Weiyuan Description and Business Overview
 Table 77. Hebei Weiyuan Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Hebei Weiyuan Pleuromutilin Antibiotic Product
 Table 79. Hebei Weiyuan Recent Developments/Updates
 Table 80. Shandong Shengli Company Information
 Table 81. Shandong Shengli Description and Business Overview
 Table 82. Shandong Shengli Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Shandong Shengli Pleuromutilin Antibiotic Product
 Table 84. Shandong Shengli Recent Developments/Updates
 Table 85. Shandong Lukang Company Information
 Table 86. Shandong Lukang Description and Business Overview
 Table 87. Shandong Lukang Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Shandong Lukang Pleuromutilin Antibiotic Product
 Table 89. Shandong Lukang Recent Developments/Updates
 Table 90. Qingdao Dierman Company Information
 Table 91. Qingdao Dierman Description and Business Overview
 Table 92. Qingdao Dierman Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Qingdao Dierman Pleuromutilin Antibiotic Product
 Table 94. Qingdao Dierman Recent Developments/Updates
 Table 95. Qilu Pharma Company Information
 Table 96. Qilu Pharma Description and Business Overview
 Table 97. Qilu Pharma Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Qilu Pharma Pleuromutilin Antibiotic Product
 Table 99. Qilu Pharma Recent Developments/Updates
 Table 100. Huvepharma Company Information
 Table 101. Huvepharma Description and Business Overview
 Table 102. Huvepharma Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Huvepharma Pleuromutilin Antibiotic Product
 Table 104. Huvepharma Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Novartis Pleuromutilin Antibiotic Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Vethellas Company Information
 Table 111. Vethellas Description and Business Overview
 Table 112. Vethellas Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Vethellas Pleuromutilin Antibiotic Product
 Table 114. Vethellas Recent Developments/Updates
 Table 115. Elanco Company Information
 Table 116. Elanco Description and Business Overview
 Table 117. Elanco Pleuromutilin Antibiotic Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Elanco Pleuromutilin Antibiotic Product
 Table 119. Elanco Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pleuromutilin Antibiotic Distributors List
 Table 123. Pleuromutilin Antibiotic Customers List
 Table 124. Pleuromutilin Antibiotic Market Trends
 Table 125. Pleuromutilin Antibiotic Market Drivers
 Table 126. Pleuromutilin Antibiotic Market Challenges
 Table 127. Pleuromutilin Antibiotic Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pleuromutilin Antibiotic
 Figure 2. Global Pleuromutilin Antibiotic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pleuromutilin Antibiotic Market Share by Type: 2024 & 2031
 Figure 4. Premix Product Picture
 Figure 5. API Powder Product Picture
 Figure 6. Global Pleuromutilin Antibiotic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pleuromutilin Antibiotic Market Share by Application: 2024 & 2031
 Figure 8. Livestock
 Figure 9. Poultry
 Figure 10. Global Pleuromutilin Antibiotic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pleuromutilin Antibiotic Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pleuromutilin Antibiotic Sales (2020-2031) & (MT)
 Figure 13. Global Pleuromutilin Antibiotic Average Price (US$/Kg) & (2020-2031)
 Figure 14. Pleuromutilin Antibiotic Report Years Considered
 Figure 15. Pleuromutilin Antibiotic Sales Share by Manufacturers in 2024
 Figure 16. Global Pleuromutilin Antibiotic Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pleuromutilin Antibiotic Players: Market Share by Revenue in Pleuromutilin Antibiotic in 2024
 Figure 18. Pleuromutilin Antibiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pleuromutilin Antibiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pleuromutilin Antibiotic Sales Market Share by Country (2020-2031)
 Figure 21. North America Pleuromutilin Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pleuromutilin Antibiotic Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pleuromutilin Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pleuromutilin Antibiotic Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pleuromutilin Antibiotic Revenue Market Share by Region (2020-2031)
 Figure 33. China Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Pleuromutilin Antibiotic Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Pleuromutilin Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Pleuromutilin Antibiotic Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Pleuromutilin Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Pleuromutilin Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Pleuromutilin Antibiotic by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Pleuromutilin Antibiotic by Type (2020-2031)
 Figure 52. Global Pleuromutilin Antibiotic Price (US$/Kg) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Pleuromutilin Antibiotic by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Pleuromutilin Antibiotic by Application (2020-2031)
 Figure 55. Global Pleuromutilin Antibiotic Price (US$/Kg) by Application (2020-2031)
 Figure 56. Pleuromutilin Antibiotic Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Pleuromutilin Market Research Report 2025
Global Tiamulin API Market Research Report 2024
Global Tiamulin Premix Market Research Report 2024
Global Valnemulin Hydrochloride Premix Market Research Report 2024
Global Tiamulinfumarate Market Research Report 2024
Global Tiamulin Hydrogen Fumarate for Veterinary Market Research Report 2024
Antitumor Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retapamulin Market Insights Forecast to 2030
Global Ceftibuten Market Research Report 2024
Global Tiamulin Fumarate Use in Animal Market Research Report 2024
Global Kirenol Market Research Report 2024
Global Strobilurin Fungicide Market Research Report 2025
Global Systemic Antibiotics Market Research Report 2024
Global Pirfenidone Drugs Market Research Report 2024
Polymyxin E Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nourseothricin Sulfate Market Research Report 2024
Global Nisin Market Research Report 2024
Colistin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal Micromolecular Drugs Market Research Report 2024
Global Hygromycin B Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions